These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3292181)

  • 21. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activity in different media of ketoconazole, miconazole and amphotericin B against Candida lusitaniae and sucrose-negative Candida tropicalis.
    Mignini F; Prenna M; Oliveri S; Cammarata E; Falcioni E; Dainelli B; Ripa S
    Chemioterapia; 1988 Feb; 7(1):38-41. PubMed ID: 3378274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
    Yamaguchi H
    Rinsho Byori; 1997 Jul; Suppl 105():182-90. PubMed ID: 9379538
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH
    Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
    Martínez MM; Mendaza P; Daza RM; Sánchez G; Martín P; Martín JE; Portero F
    Rev Esp Quimioter; 1998 Sep; 11(3):251-3. PubMed ID: 9795312
    [No Abstract]   [Full Text] [Related]  

  • 29. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
    Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antifungal activity of oxygenated cholesterol derivatives.
    Brunel JM; Loncle C; Vidal N; Dherbomez M; Letourneux Y
    Steroids; 2005 Dec; 70(13):907-12. PubMed ID: 16139854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of the newer quinolones compared with the classic ones and tobramycin.
    Boquet Jiménez E; Dalet Escribá F; Caballé L
    Infection; 1985; 13(4):193-6. PubMed ID: 2931382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of the sensitivity to antifungal agents of clinical isolates of Candida albicans serotype A and B by the ATB Fungus method].
    Quindós G; San Millán R; Burgos A; Lipperheide V; Tellaetxe M; Alonso R; Barturen B; Pontón J
    Enferm Infecc Microbiol Clin; 1995 Apr; 13(4):209-12. PubMed ID: 7779872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains].
    Yalçin B; Kalkanci A; Gürelik F; Fidan I; Kustimur S; Ozdek S
    Mikrobiyol Bul; 2010 Jan; 44(1):65-70. PubMed ID: 20455400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro activity of commonly used antifungal agents in the presence of rifampin, polymyxin B and norfloxacin against Candida albicans.
    Moneib NA
    J Chemother; 1995 Dec; 7(6):525-9. PubMed ID: 8667037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
    Shrire L; Saunders J; Traynor R; Koornhof HJ
    Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.
    Siau H; Kerridge D
    J Antimicrob Chemother; 1998 Mar; 41(3):357-66. PubMed ID: 9578162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
    Delmee M; Avesani V
    Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
    Neu HC
    J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sertaconazole: in-vitro antifungal activity against vaginal and other superficial yeast isolates.
    Carrillo-Muñoz AJ; Brió S; Quindós G; Palacín C; Guglietta A; Espinel-Ingroff A
    J Chemother; 2001 Oct; 13(5):555-62. PubMed ID: 11760221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.